Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210491160> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3210491160 abstract "<h3>Objectives</h3> Neoadjuvant chemotherapy (NACT) plus interval debulking surgery (IDS) is a treatment strategy for ovarian cancer patients with unresectable disease or poor performance status. It has also used for the treatment of advanced endometrial cancer (ECa) and a survival benefit has been shown. This study reviews our single-institution experience with NACT and surgery for advanced endometrial cancer. <h3>Methods</h3> Data were collected retrospectively about patients with ECa treated January 2015-March 2021. Outcome measures include response; survival; and treatment-related morbidity. <h3>Results</h3> There were 18 patients aged 39–72yrs. Data is complete for 16 (two had surgery overseas). Histological type was: endometrioid (72%); serous (22%); mixed (6%). 33% were stage IV; 45% stage III; 22% stage II. All patients received Carboplatin/Paclitaxel chemotherapy. Two also received radiotherapy before surgery. Patients received between 2–6 cycles of chemotherapy. Fifteen patients (83.3%) had optimal debulking surgery and one sub-optimal debulking. One patient was lost to follow-up. Another expired before surgery due to septic shock. Data regarding survival is available for 14/18 patients. One has died. Thirteen patients are alive with survival of 6–48mth. Two patients are alive with recurrence. Eleven are alive without recurrence. Overall median survival is currently 20mth. 83% had no significant complications; 11% had wound infection; one patient died from septic shock. <h3>Conclusions</h3> NACT and IDS delivers high rates of optimal debulking in patients with advanced stage ECa. There are acceptable levels of morbidity. This study suggests that NACT followed by IDS is at least a non-inferior strategy for patients with advanced ECa who are unsuitable for primary surgery." @default.
- W3210491160 created "2021-11-08" @default.
- W3210491160 creator A5014520619 @default.
- W3210491160 creator A5027101538 @default.
- W3210491160 creator A5051148503 @default.
- W3210491160 creator A5056161932 @default.
- W3210491160 creator A5060558104 @default.
- W3210491160 creator A5066780671 @default.
- W3210491160 creator A5078058225 @default.
- W3210491160 date "2021-11-01" @default.
- W3210491160 modified "2023-09-27" @default.
- W3210491160 title "EPV124/#439 Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer" @default.
- W3210491160 doi "https://doi.org/10.1136/ijgc-2021-igcs.194" @default.
- W3210491160 hasPublicationYear "2021" @default.
- W3210491160 type Work @default.
- W3210491160 sameAs 3210491160 @default.
- W3210491160 citedByCount "0" @default.
- W3210491160 crossrefType "proceedings-article" @default.
- W3210491160 hasAuthorship W3210491160A5014520619 @default.
- W3210491160 hasAuthorship W3210491160A5027101538 @default.
- W3210491160 hasAuthorship W3210491160A5051148503 @default.
- W3210491160 hasAuthorship W3210491160A5056161932 @default.
- W3210491160 hasAuthorship W3210491160A5060558104 @default.
- W3210491160 hasAuthorship W3210491160A5066780671 @default.
- W3210491160 hasAuthorship W3210491160A5078058225 @default.
- W3210491160 hasBestOaLocation W32104911601 @default.
- W3210491160 hasConcept C121608353 @default.
- W3210491160 hasConcept C126322002 @default.
- W3210491160 hasConcept C141071460 @default.
- W3210491160 hasConcept C146357865 @default.
- W3210491160 hasConcept C150173356 @default.
- W3210491160 hasConcept C151730666 @default.
- W3210491160 hasConcept C2776694085 @default.
- W3210491160 hasConcept C2777088508 @default.
- W3210491160 hasConcept C2778239845 @default.
- W3210491160 hasConcept C2780427987 @default.
- W3210491160 hasConcept C2781100745 @default.
- W3210491160 hasConcept C2781451048 @default.
- W3210491160 hasConcept C509974204 @default.
- W3210491160 hasConcept C71924100 @default.
- W3210491160 hasConcept C86803240 @default.
- W3210491160 hasConceptScore W3210491160C121608353 @default.
- W3210491160 hasConceptScore W3210491160C126322002 @default.
- W3210491160 hasConceptScore W3210491160C141071460 @default.
- W3210491160 hasConceptScore W3210491160C146357865 @default.
- W3210491160 hasConceptScore W3210491160C150173356 @default.
- W3210491160 hasConceptScore W3210491160C151730666 @default.
- W3210491160 hasConceptScore W3210491160C2776694085 @default.
- W3210491160 hasConceptScore W3210491160C2777088508 @default.
- W3210491160 hasConceptScore W3210491160C2778239845 @default.
- W3210491160 hasConceptScore W3210491160C2780427987 @default.
- W3210491160 hasConceptScore W3210491160C2781100745 @default.
- W3210491160 hasConceptScore W3210491160C2781451048 @default.
- W3210491160 hasConceptScore W3210491160C509974204 @default.
- W3210491160 hasConceptScore W3210491160C71924100 @default.
- W3210491160 hasConceptScore W3210491160C86803240 @default.
- W3210491160 hasLocation W32104911601 @default.
- W3210491160 hasOpenAccess W3210491160 @default.
- W3210491160 hasPrimaryLocation W32104911601 @default.
- W3210491160 hasRelatedWork W1966901273 @default.
- W3210491160 hasRelatedWork W2014215628 @default.
- W3210491160 hasRelatedWork W2020778541 @default.
- W3210491160 hasRelatedWork W2170977668 @default.
- W3210491160 hasRelatedWork W2334586857 @default.
- W3210491160 hasRelatedWork W2592014838 @default.
- W3210491160 hasRelatedWork W2953658820 @default.
- W3210491160 hasRelatedWork W3180599892 @default.
- W3210491160 hasRelatedWork W4282970320 @default.
- W3210491160 hasRelatedWork W59268075 @default.
- W3210491160 isParatext "false" @default.
- W3210491160 isRetracted "false" @default.
- W3210491160 magId "3210491160" @default.
- W3210491160 workType "article" @default.